Abstract: The present disclosure provides a method for treating or preventing endothelial dysfunction in a subject, the method comprising systemically administering to the subject a population of population of cells enriched for STRO-1+ cells and/or progeny thereof and/or soluble factors derived therefrom.

Abstract: Various COx electrolyzer multi-cell architectures are provided, including various frame, flow field, gas diffusion layer, and repeat unit designs that may be particularly useful in the context of multi-cell COx electrolyzer cells.

Abstract: Described are oxysterols, pharmaceutical compositions including the oxysterols, and methods of using the oxysterols and compositions for treating diseases and/or disorders related to inflammation, such as necrotizing enterocolitis, mesenteric ischemia, inflammatory bowel diseases including Crohn's disease and ulcerative colitis, lymphocytic colitis, Celiac disease, Behcet's disease, rheumatoid arthritis, psoriasis, and autoimmune thyroid disease.

Abstract: Described are oxysterols, pharmaceutical compositions including the oxysterols, and methods of using the oxysterols and compositions for treating diseases and/or disorders related to inflammation, such as necrotizing enterocolitis, mesenteric ischemia, inflammatory bowel diseases including Crohn's disease and ulcerative colitis, lymphocytic colitis, Celiac disease. Behcet's disease, rheumatoid arthritis, psoriasis, and autoimmune thyroid disease.

Abstract: Various COx electrolyzer cell architectures are provided, including various flow field designs and gas diffusion layer designs that may be particularly useful in the context of COx electrolyzer cells.

Abstract: Described are oxysterols, pharmaceutical compositions including the oxysterols, and methods of using the oxysterols and compositions for treating diseases and/or disorders related to inflammation, such as necrotizing enterocolitis, mesenteric ischemia, inflammatory bowel diseases including Crohn's disease and ulcerative colitis, lymphocytic colitis, Celiac disease. Behcet's disease, rheumatoid arthritis, psoriasis, and autoimmune thyroid disease.

Abstract: Methods and systems to process computer readable electronic messages, such as electronic mail messages or e-mail. Methods and system include auto-tagging based on one or more of statistical machine learning based clustering techniques, custom parsers, and crowd-sourced message tagging. Methods and systems further include relevancy determination based on combinations of features, user-configurable hybrid web browser/e-mail client rendering, tabbed rendering, plug-in based local computational features, implied social graph based decision making, and automatic detection of account settings.

Abstract: Methods and systems to present a relatively small combinational set of user-selectable filter and display criteria, through a relatively small number of visually-intuitive controls of an electronic message (EM) graphical user interface (GUI), and to translate a combination of user-selected criteria to a more-complex set of configuration parameters. Methods and systems disclosed herein may be implemented to provide filter and/or display configurations on-par or greater than conventional EM clients, in quantity and/or complexity, with less user-effort, knowledge, and navigational skill.

Abstract: Methods and systems to process computer readable electronic messages, such as electronic mail messages or e-mail. Methods and system include auto-tagging based on one or more of statistical machine learning based clustering techniques, custom parsers, and crowd-sourced message tagging. Methods and systems further include relevancy determination based on combinations of features, user-configurable hybrid web browser/e-mail client rendering, tabbed rendering, plug-in based local computational features, implied social graph based decision making, and automatic detection of account settings.

Abstract: The invention relates to predicting, or aiding in predicting, which individuals are at risk of developing coronary artery disease. The invention provides a method for identifying an individual who has an altered risk for developing CAD. The invention further relates to methods of reducing the likelihood that a subject will develop CAD. The invention further provides reagents, nucleic acids and kits comprising nucleic acids containing a polymorphism in a CAD-determinative gene.

Abstract: The present invention provides methods of identifying a subject having an increased or decreased risk of developing cardiovascular disease, comprising: a) correlating the presence of one or more genetic markers in chromosome 3q13.31 with an increased or decreased risk of developing cardiovascular disease; and b) detecting the one or more genetic markers of step (a) in the subject, thereby identifying the subject as having an increased or decreased risk of developing cardiovascular disease. Also provided are methods of identifying subjects with cardiovascular disease as having a good or poor prognosis, as well as methods of identifying effective treatment regimens for cardiovascular disease, based on correlation with genetic markers in chromosome 3q13.31.